Talis Biomedical Corporation (TLIS) OTC

2.84

+0(+0.00%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap13.54M
Enterprise Value-43.52M
P/E Ratio-0.08
PEG Ratio-0
Price/Sales Ratio12.57
Price/Book Ratio0.07
Enterprise/Revenue-125.94
Enterprise/EBITDA0.79

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-150.5
Operating Margin-162.17

Management Effectiveness

Return On Assets-0.65
Return On Equity-0.63

Income Statement

Revenue412,000
Revenue/Share0.23
Gross Profit371,000
EBITDA-66.05M
Net Income-62.01M
Diluted EPS-34.12

Balance Sheet

Total Cash59.87M
Total Cash/Share42.22
Total Debt18.8M
Total Debt/Equity0.28
Current Ratio8.86
Book Value Per Share38.03

Price History

52-Week Change83.23
52-Week High2.84
52-Week Low1.04
Moving Average 50 Days2.07
Moving Average 200 Days1.65

Statistics

Average Volume1,227
Shares Outstanding1.82M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateJuly 06, 2023